期刊文献+

丁螺环酮联合帕罗西汀对老年抑郁症伴焦虑症状的效果分析 被引量:3

Analysis of the Effect of Buspirone Combined with Paroxetine on Elderly Depression with Anxiety Symptoms
下载PDF
导出
摘要 目的探讨对老年抑郁症伴焦虑症状患者实施丁螺环酮联合帕罗西汀治疗的效果。方法便利选取2019年10月—2020年12月该院精神科收治的160例老年抑郁症伴焦虑症状患者,将其按照随机数字表法予以分组,每组80例。对照组实施帕罗西汀治疗,研究组实施丁螺环酮联合帕罗西汀治疗,对比分析两组临床效果。结果治疗前,两组HAMD评分对比差异无统计学意义(P>0.05);对照组治疗2周、4周、8周后HAMD评分分别为(28.89±4.46)分、(26.89±5.61)分、(18.51±5.62)分,研究组治疗2周、4周、8周HAMD评分分别为(17.56±4.10)分、(13.10±3.56)分、(9.81±1.45)分,研究组治疗后HAMD评分低于对照组,差异有统计学意义(t=16.727、18.563、13.407,P<0.001)。治疗前,两组HAMA评分对比差异无统计学意义(P>0.05);对照组治疗2周、4周、8周后HAMA评分分别为(20.89±4.56)分、(19.89±5.56)分、(18.08±3.10)分,研究组治疗2周、4周、8周后HAMA评分分别为(18.23±4.78)分、(16.10±3.36)分、(7.77±2.78)分,研究组治疗后HAMA评分低于对照组,差异有统计学意义(t=14.432、5.218、22.146,P<0.001)。从副反应量表(TESS)评分分析,治疗2周、4周、8周两组评分对比差异无统计学意义(P>0.05)。结论对于老年抑郁症伴焦虑症状患者而言,丁螺环酮联合帕罗西汀治疗效果更佳,可使抑郁和焦虑症状得到有效改善,而且安全性良好,临床价值显著。 Objective To odiscuss the effect of buspirone combined with paroxetine in the treatment of senile depression with anxiety symptoms.Methods A total of 160 elderly patients with depression and anxiety symptoms admitted to the psychiatric department of the hospital from October 2019 to December 2020 were convenient selected and divided into groups according to random number table method,with 80 cases in each group.The control group was treated with paroxetine,and the study group was treated with buspirone combined with paroxetine.The clinical effects of the two groups were compared and analyzed.Results Before treatment,there was no statistically significant difference in HAMD score between the two groups(P>0.05).The HAMD scores of the control group were(28.89±4.46)points,(26.89±5.61)points,(18.51±5.62)points after 2,4 and 8 weeks of treatment,respectively.The HAMD scores of the study group were(17.56±4.10)points,(13.10±3.56)points and(9.81±1.45)points after 2,4 and 8 weeks of treatment,respectively.The HAMD scores of the study group were lower than those of the control group,and the differences were statistically significant(t=16.727,18.563,13.407,P<0.001).Before treatment,there was no statistically significant difference in HAMA scores between the two groups(P>0.05).HAMA scores of control group were(20.89±4.56)points,(19.89±5.56)points,(18.08±3.10)points after 2,4 and 8 weeks of treatment,respectively.HAMA scores in the study group were(18.23±4.78)points,(16.10±3.36)points and(7.77±2.78)points after 2,4 and 8 weeks of treatment,respectively.HAMA scores in the study group were lower than those in the control group,and the differences were statistically significant(t=14.432,5.218,22.146,P<0.001).According to the analysis of TESS score,there was no statistically significant difference between the two groups at 2,4 and 8 weeks of treatment(P>0.05).Conclusion Buspirone combined with paroxetine is more effective in the treatment of senile depression with anxiety symptoms,which can effectively improve the symp
作者 顾凤华 GU Fenghua(Department of Psychosomatic,Taicang Third People's Hospital,Taicang,Jiangsu Province,215400 China)
出处 《中外医疗》 2021年第26期104-107,共4页 China & Foreign Medical Treatment
关键词 丁螺环酮 帕罗西汀 老年患者 抑郁症 焦虑症状 效果 Buspirone Paroxetine Elderly patients Depression Anxiety symptoms Effect
  • 相关文献

参考文献13

二级参考文献105

  • 1Devanand DP.Comorbid psychiatric disorders in late depression[J].Biol Psychiatry,2002,52(3):236. 被引量:1
  • 2Lenze EJ,Mulsant BH,Shear MK,et al.Comorbid anxiety disorders in depressed elderly patients[J].Am J Psychiatry,2000,157(5):722. 被引量:1
  • 3Jacoby R.Psychiatry in the elderly[M].2nd.New York:Oxford University Press,1997:536-573. 被引量:1
  • 4Thase ME,Shelton RC,Khan A.Treatment with venlafaxine extended release after SSRI nonresponse orintolerance:a randomized comparison of standard 2 and higher 2dosing strategies[J].J Clin Psychopharmacol,2006,26(3):250. 被引量:1
  • 5Moroz G.High potency benzodiazepines:recent clinical results[J].Clin J Psychiatry,2004,65(5):13. 被引量:1
  • 6Gobert A,Rivet JM,Cistarelli L,et al.Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine,noradrenaline and serotonin in the frontal cortex of freely moving rats:activation of serotonin1A receptors and blockade ofα2-adrenergic receptors underlie its actions[J].Neuroscience,1999,93(4):1 251. 被引量:1
  • 7Gross C,Zhuang X,Stark K,et al.Serotoninl A receptor acts during development to establish normal anxiety-like behavior in the adult[J].Nature,2002,416(6 879):396. 被引量:1
  • 8Sato H,Skelin I,Diksic M.Chronic buspirone treatment decreases 5-HT1BReceptor densitises and the serotonin transporter but increases the density of 5-HT2Areceptors in the bulbectomized rat model of depression:an autoradiograpic study[J].Brain Res,2010,1 345:28. 被引量:1
  • 9Loane C,Politis M.Buspirone:what is it all about?[J].Brain Research,2012,1 461:111. 被引量:1
  • 10Fang Y,Yuan C,Xu Y,et al.A pilot study of the efficacy and safety of paroxetine augmented with risperidone,valproate,buspirone,trazodone,or thyroid hormone in adult chinese patients with treatment-resistant major depression[J].J Clin Psychopharmacol,2011,31(5):1. 被引量:1

同被引文献32

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部